President and CEO of Seattle Genetics, Inc. (SGEN) Clay B Siegall sells 8,250 shares of SGEN on 11/01/2012 at an average price of $25.51 a share.

Seattle Genetics, Inc. has a market cap of $3 billion; its shares were traded at around $24.33 with and P/S ratio of 31.7. Seattle Genetics, Inc. had an annual average earning growth of 3.2% over the past 10 years. GuruFocus rated Seattle Genetics, Inc. the business predictability rank of 3-star.

CEO Recent Trades:

President and CEO Clay B Siegall sold 8,250 shares of SGEN stock on 11/01/2012 at the average price of 25.51. Clay B Siegall owns at least 1,170,961 shares after this. The price of the stock has decreased by 4.63% since.

President and CEO Clay B Siegall sold 8,250 shares of SGEN stock on 10/01/2012 at the average price of 26.59. Clay B Siegall owns at least 1,170,961 shares after this. The price of the stock has decreased by 8.5% since.

President and CEO Clay B Siegall sold 8,250 shares of SGEN stock on 09/04/2012 at the average price of 26.54. Clay B Siegall owns at least 1,170,961 shares after this. The price of the stock has decreased by 8.33% since.

President and CEO Clay B Siegall sold 8,250 shares of SGEN stock on 08/02/2012 at the average price of 26. Clay B Siegall owns at least 1,096,711 shares after this. The price of the stock has decreased by 6.42% since.

President & CEO Clay B Siegall sold 8,250 shares of SGEN stock on 07/02/2012 at the average price of 25.36. Clay B Siegall owns at least 1,096,711 shares after this. The price of the stock has decreased by 4.06% since.

CFO Recent Trades:

CFO Todd E Simpson sold 95,000 shares of SGEN stock on 09/06/2012 at the average price of 28.5. Todd E Simpson owns at least 70,762 shares after this. The price of the stock has decreased by 14.63% since.

CFO Todd E Simpson sold 45,000 shares of SGEN stock on 08/27/2012 at the average price of 26.97. Todd E Simpson owns at least 70,762 shares after this. The price of the stock has decreased by 9.79% since.

CFO Todd E Simpson sold 40,000 shares of SGEN stock on 08/16/2012 at the average price of 25.97. Todd E Simpson owns at least 50,762 shares after this. The price of the stock has decreased by 6.31% since.

CFO Todd E Simpson sold 95,000 shares of SGEN stock on 06/14/2012 at the average price of 24.5. Todd E Simpson owns at least 50,762 shares after this. The price of the stock has decreased by 0.69% since.

CFO Todd E Simpson sold 35,000 shares of SGEN stock on 06/08/2012 at the average price of 22.97. Todd E Simpson owns at least 50,762 shares after this. The price of the stock has increased by 5.92% since.

Directors and Officers Recent Trades:

COO Eric Dobmeier sold 25,000 shares of SGEN stock on 10/15/2012 at the average price of 25.01. Eric Dobmeier owns at least 69,352 shares after this. The price of the stock has decreased by 2.72% since.

EVP, Tech. Ops. & Proc. Sci. Vaughn B Himes sold 10,000 shares of SGEN stock on 09/10/2012 at the average price of 28.79. Vaughn B Himes owns at least 33,643 shares after this. The price of the stock has decreased by 15.49% since.

Chief Medical Officer Thomas C Reynolds sold 48,540 shares of SGEN stock on 09/06/2012 at the average price of 29.75. Thomas C Reynolds owns at least 57,601 shares after this. The price of the stock has decreased by 18.22% since.

COO Eric Dobmeier sold 25,000 shares of SGEN stock on 08/13/2012 at the average price of 24.01. Eric Dobmeier owns at least 43,352 shares after this. The price of the stock has increased by 1.33% since.

COO Eric Dobmeier sold 25,000 shares of SGEN stock on 06/18/2012 at the average price of 25.36. Eric Dobmeier owns at least 68,073 shares after this. The price of the stock has decreased by 4.06% since.

Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC.
Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.